BookCataldo Doria, Jason N. Rogart, editors.
Summary: Hepato-Pancreato-Biliary cancers are increasing in incidence, with pancreatic cancer now accounting for the third most cancer deaths in the United States. Typically these malignancies, as a group, are managed by the same key providers comprising a multidisciplinary team. This book is intended to provide a comprehensive review of the current knowledge in the field of hepato-pancreato-biliary malignancies, focusing on the practical and clinical care of patients. We take the approach of combining the collective expertise of an interventional gastroenterologist and a hepato-pancreato-biliary surgeon to provide the readers with accurate, succinct, and pragmatic information needed to formulate the most appropriate treatment plan for their patients with the aim of the best possible outcome. Managing patients with these cancers continues to be challenging because of continued dismal survival rates. Each section in this text is written by experts in their respective field, summarizing the most state-of-the-art, contemporary diagnostic and therapeutic tools available in the field. We believe this book will prove to be an invaluable, comprehensive resource for all members of the multidisciplinary team caring for patients with hepato-pancreato-biliary malignancies.
Contents:
Approach to the patient with a solid liver mass
Pathogenesis, Epidemiology and Prognosis of Hepatocellular carcinoma (HCC)
HCC Pathology
Diagnosis and Evaluation of HCC
Liver-directed therapy (IR) for HCC
Medical Management of HCC
Surgical Management of HCC
Treatment of liver metastasis from colorectal cancer
Treatment of isolated liver metastasis from non-colorectal cancer
Pathogenesis, Epidemiology and Prognosis of Uncommon Liver Tumors
Diagnosis and Management of Uncommon Liver Tumors
Reducing the Risk of and Screening for Liver Cancer
Pathogenesis, Epidemiology and Prognosis of Cholangiocarcinoma
Pathology of Cholangiocarcinoma
Diagnosis and Evaluation of Cholangiocarcinoma
Nonsurgical Management of Cholangiocarcinoma
Surgical Management of Cholangiocarcinoma
How do I approach Klatskin’s tumor
Endoscopic Palliative Management of Cholangiocarcinoma
Rare Tumors of the Bile Ducts: Pathogenesis, Epidemiology, Diagnosis, and Management
Pathogenesis, Epidemiology and Prognosis of Gallbladder Cancer
Diagnosis and Evaluation of Gallbladder Cancer
Pathology of Gallbladder Cancer
Nonsurgical Management of Gallbladder Cancer
Surgical Management of Gallbladder Cancer
Approach to the Patient with a Pancreatic Mass
Evaluation and Management of the Patient with a Pancreatic Cyst
Pathogenesis, Epidemiology and Prognosis of Pancreatic Adenocarcinoma
Diagnosis and Evaluation of Pancreatic Adenocarcinoma
Pathology of Pancreatic Adenocarcinoma
Nonsurgical management of Pancreatic Adenocarcinoma,- Surgical management of Pancreatic Adenocarcinoma
Intra-operative radiation treatment
Endoscopic Palliative Management of Pancreatic Adenocarcinoma
Reducing the Risk of and Screening for Pancreatic Cancer
Pathogenesis, Epidemiology and Prognosis of Pancreatic Neuroendocrine Tumors
Pathology of Pancreatic Neuroendocrine Tumors
Diagnosis and Evaluation of Pancreatic Neuroendocrine Tumors
Nonsurgical management of Pancreatic Neuroendocrine Tumors
Surgical Management of Pancreatic Neuroendocrine Tumors
Emerging endoscopic therapies for Pancreatic Neuroendocrine Tumors
Pathogenesis and Pathology of Rare Pancreatic Neoplasms
Diagnosis and Management of Rare Pancreatic Neoplasms
Molecular and Genetic Profiling for Diagnosis and Therapy of Hepatobiliary and Pancreatic Malignancies
The Role of Robotic Surgery in Treating Hepatobiliary and Pancreatic Malignancies
The Importance of the Multidisciplinary Approach to Managing Hepatobiliary and Pancreatic Malignancies
The Role of the Palliative Care Team in the Management of Hepatobiliary and Pancreatic Malignancies
The Role of Alternative Medicine in the Management of Hepatobiliary and Pancreatic Malignancies
Integrative Medicine and Hepatobiliary and Pancreatic Cancer: What to Expect
Is Personalized Medicine Truly Making a Difference for Patients Diagnosed with Cancers of the Liver, Biliary Tract, and Pancreas.